Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rakovina Therapeutics Inc V.RKV

Alternate Symbol(s):  RKVTF

Rakovina Therapeutics Inc. is a Canada-based biopharmaceutical company. The Company is engaged in advancing cancer therapies based on deoxyribonucleic acid (DNA)-damage response technologies. The Company has a pipeline of DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials and obtain marketing approval for cancer therapeutics. The Company’s research... see more

Recent & Breaking News (TSXV:RKV)

Rakovina Therapeutics Announces Non-dilutive Financial Contributions to Support Lead Optimization of Novel Anti-cancer Agents

GlobeNewswire December 21, 2021

Rakovina Therapeutics Inc. Announces Third Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire November 23, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Partnership with St. Baldrick's Foundation to Research and Develop New Treatments for Childhood Bone Cancer - Video Available on Investmentpitch.com

Newsfile November 17, 2021

The Power Play by The Market Herald Releases New Interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy DeFi, and Saturn Oil & Gas Discussing Their Latest Press Releases

Accesswire November 16, 2021

Rakovina Therapeutics (TSXV:RKV) partners with St. Baldrick’s Foundation

Trevor Abes  November 16, 2021

Rakovina Therapeutics Partners with St. Baldrick's Foundation to Research and Develop New Treatments for Childhood Bone Cancer

GlobeNewswire November 16, 2021

Rakovina Therapeutics Presents at the 6th biennial Canadian Cancer Research Conference

GlobeNewswire November 11, 2021

Rakovina Therapeutics to Present at the 6th biennial Canadian Cancer Research Conference

GlobeNewswire October 21, 2021

Rakovina Therapeutics Presents at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire October 12, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Receipt of Notice of Allowance for New U.S. Patent Covering kt-2000 Series PARP Inhibitors - Video Available on Investmentpitch.com

Newsfile October 8, 2021

Rakovina Therapeutics Inc. Receives Notice of Allowance for New U.S. Patent Covering kt-2000 series PARP Inhibitors

GlobeNewswire October 7, 2021

Rakovina Therapeutics Presents Preclinical Data on novel kt-3000 Series Drug Candidates at JCA-AACR Precision Medicine International Conference

GlobeNewswire September 16, 2021

Rakovina Therapeutics to Present at the JCA-AACR Precision Medicine International Conference

GlobeNewswire September 9, 2021

Rakovina Therapeutics Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update

GlobeNewswire August 26, 2021

Rakovina Therapeutics to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

PR Newswire August 17, 2021

Notice Regarding Effectiveness of Voluntary Delisting of American Depositary Receipts ("ADRs") from the New York Stock Exchange ("NYSE")

Accesswire July 12, 2018

VIÑA CONCHA Y TORO S.A. Announces Voluntary Delisting of American Depositary Receipts from the New York Stock Exchange

Accesswire June 21, 2018

Mid-Morning Market Update: Markets Mixed; AutoZone Profit Beats Expectations

Benzinga.com  May 22, 2018

Viña Concha Y Toro Announces Filing of its Form 20-F 2017

Accesswire April 30, 2018

Vina Concha y Toro Announces Filing of Its Form 20-F 2016

Marketwired May 16, 2017